301 related articles for article (PubMed ID: 15647846)
1. FISH analysis of native smears from bone marrow and blood for the monitoring of chimerism and clonal markers after stem cell transplantation in children.
Fuehrer M; Gerusel-Bleck M; Konstantopoulos N; Bender-Goetze C; Walther JU
Int J Mol Med; 2005 Feb; 15(2):291-7. PubMed ID: 15647846
[TBL] [Abstract][Full Text] [Related]
2. Conventional cytogenetics and FISH evaluation of chimerism after sex-mismatched bone marrow transplantation (BMT) and donor leukocyte infusion (DLI).
Díez-Martín JL; Llamas P; Gosálvez J; López-Fernández C; Polo N; de la Fuente MS; Buño I
Haematologica; 1998 May; 83(5):408-15. PubMed ID: 9658724
[TBL] [Abstract][Full Text] [Related]
3. Fluorescent in situ hybridization on flow-sorted cells as a tool for evaluating minimal residual disease or chimerism after allogenic bone marrow transplantation.
Cotteret S; Belloc F; Boiron JM; Bilhou-Nabera C; Dumain P; Boyer C; Lacombe F; Reiffers J; Bernard P
Cytometry; 1998 Oct; 34(5):216-22. PubMed ID: 9822307
[TBL] [Abstract][Full Text] [Related]
4. Establishing the method of chimerism monitoring after allogeneic stem cell transplantation using multiplex polymerase chain reaction amplification of short tandem repeat markers and Amelogenin.
Sufliarska S; Minarik G; Horakova J; Bodova I; Bojtarova E; Czako B; Mistrik M; Drgona L; Demitrovicova M; Lakota J; Krivosikova M; Kovacs L
Neoplasma; 2007; 54(5):424-30. PubMed ID: 17688372
[TBL] [Abstract][Full Text] [Related]
5. [Study of the time course of mixed chimerism by fluorescent in situ hybridization in patients with chronic myeloid leukemia after allogenic transplantation of bone marrow].
Vinogradova OA; Savchenko VG; Neverova AL; Diachenko LV; Domracheva EV; Liubimova LS; Mendeleeva LP
Ter Arkh; 2001; 73(7):26-34. PubMed ID: 11523405
[TBL] [Abstract][Full Text] [Related]
6. [Application of sequential and quantitative monitoring of chimerism in allogeneic hematopoietic stem cell transplantation].
Tang XW; Wu DP; Zhu ZL; Wang W; Sun AN; Qiu HY; Fu ZZ; Chang WR; Ruan CG
Zhonghua Xue Ye Xue Za Zhi; 2004 Feb; 25(2):78-81. PubMed ID: 14990044
[TBL] [Abstract][Full Text] [Related]
7. Detection of mixed chimerism and leukemic relapse after allogeneic bone marrow transplantation in subpopulations of leucocytes by fluorescent in situ hybridization in combination with the simultaneous immunophenotypic analysis of interphase cells.
Kögler G; Wolf HH; Heyll A; Arkesteijn G; Wernet P
Bone Marrow Transplant; 1995 Jan; 15(1):41-8. PubMed ID: 7742754
[TBL] [Abstract][Full Text] [Related]
8. [The clinical significance of interphase fluorescence in situ hybridization monitoring chimeric status after sex-mismatched allogeneic hematopoietic stem cell transplantation for leukemia].
Liu Q; Song L; Zhang Y; Wei Y; Xu D; Sun J; Liu X; Xu B; Meng F; Zhou S
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Apr; 22(2):212-5. PubMed ID: 15793790
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of chimerism after allogeneic stem cell transplantation by real-time polymerase chain reaction with single nucleotide polymorphisms, standard tandem repeats, and Y-chromosome-specific sequences.
Koldehoff M; Steckel NK; Hlinka M; Beelen DW; Elmaagacli AH
Am J Hematol; 2006 Oct; 81(10):735-46. PubMed ID: 16838323
[TBL] [Abstract][Full Text] [Related]
10. FISH detection of mixed chimerism in 33 patients submitted to bone marrow transplantation.
Palka G; Stuppia L; Di Bartolomeo P; Morizio E; Peila R; Franchi PG; Calabrese G
Bone Marrow Transplant; 1996 Feb; 17(2):231-6. PubMed ID: 8640172
[TBL] [Abstract][Full Text] [Related]
11. A comparison of fluorescent in situ hybridization and multiplex short tandem repeat polymerase chain reaction for quantifying chimerism after stem cell transplantation.
Buño I; Nava P; Simón A; González-Rivera M; Jiménez JL; Balsalobre P; Serrano D; Carrión R; Gómez-Pineda A; Díez-Martín JL
Haematologica; 2005 Oct; 90(10):1373-9. PubMed ID: 16219574
[TBL] [Abstract][Full Text] [Related]
12. Leukemic relapse in the central nervous system after allogeneic stem cell transplantation with complete remission in the bone marrow and donor-type chimerism: report of two cases.
Ohashi H; Kato C; Fukami S; Saito H; Hamaguchi M
Am J Hematol; 2005 Jun; 79(2):142-6. PubMed ID: 15929112
[TBL] [Abstract][Full Text] [Related]
13. Detection of residual host cells after bone marrow transplantation using non-isotopic in situ hybridization and karyotype analysis.
Wessman M; Popp S; Ruutu T; Volin L; Cremer T; Knuutila S
Bone Marrow Transplant; 1993 Apr; 11(4):279-84. PubMed ID: 8485475
[TBL] [Abstract][Full Text] [Related]
14. Serial chimerism analyses indicate that mixed haemopoietic chimerism influences the probability of graft rejection and disease recurrence following allogeneic stem cell transplantation (SCT) for severe aplastic anaemia (SAA): indication for routine assessment of chimerism post SCT for SAA.
Lawler M; McCann SR; Marsh JC; Ljungman P; Hows J; Vandenberghe E; O'Riordan J; Locasciulli A; Socié G; Kelly A; Schrezenmeier H; Marin P; Tichelli A; Passweg JR; Dickenson A; Ryan J; Bacigalupo A;
Br J Haematol; 2009 Mar; 144(6):933-45. PubMed ID: 19183198
[TBL] [Abstract][Full Text] [Related]
15. Engraftment and chimerism, particularly of T- and B-cells, in children undergoing allogeneic bone marrow transplantation.
Winiarski J; Mattsson J; Gustafsson A; Wester D; Borgström B; Ringdén O; Ljungman P; Dalianis T
Pediatr Transplant; 1998 May; 2(2):150-6. PubMed ID: 10082448
[TBL] [Abstract][Full Text] [Related]
16. Monitoring of chimerism after allogeneic bone marrow transplantation with unmanipulated marrow by use of DNA polymorphisms.
Suttorp M; Schmitz N; Dreger P; Schaub J; Löffler H
Leukemia; 1993 May; 7(5):679-87. PubMed ID: 8097800
[TBL] [Abstract][Full Text] [Related]
17. Differences in proportion and dynamics of recipient hematopoiesis following hematopoietic cell transplantation in CML and IMF.
Siebolts U; Thiele J; Zander T; Ditschkowski M; Beelen DW; Kröger N; Fehse B; Wickenhauser C
Oncol Rep; 2008 Jan; 19(1):287-92. PubMed ID: 18097609
[TBL] [Abstract][Full Text] [Related]
18. Detection of relapse by sequential monitoring of chimerism in circulating CD34+ cells.
Thiede Ch; Lutterbeck K; Oelschlägel U; Kiehl M; Steudel Ch; Platzbecker U; Brendel C; Fauser AA; Neubauer A; Ehninger G; Bornhäuser M
Ann Hematol; 2002; 81 Suppl 2():S27-8. PubMed ID: 12611065
[TBL] [Abstract][Full Text] [Related]
19. Early complete donor hematopoietic chimerism in peripheral blood indicates the risk of extensive graft-versus-host disease.
Balon J; Hałaburda K; Bieniaszewska M; Reichert M; Bieniaszewski L; Piekarska A; Pawłowski R; Hellmann A
Bone Marrow Transplant; 2005 Jun; 35(11):1083-8. PubMed ID: 15821766
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stem cells remain of host origin even a long time after allogeneic peripheral blood stem cell or bone marrow transplantation.
Rieger K; Marinets O; Fietz T; Körper S; Sommer D; Mücke C; Reufi B; Blau WI; Thiel E; Knauf WU
Exp Hematol; 2005 May; 33(5):605-11. PubMed ID: 15850839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
